NEW YORK--(BUSINESS WIRE)--Pfizer Inc announced today that Caduet® (amlodipine besylate and atorvastatin calcium), the first single pill that treats both high blood pressure and high cholesterol, has ...

PRINCETON, N.J. & GURGAON, India--(BUSINESS WIRE)-- Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd. (RLL, NSE: RANBAXY, BSE: 500359) (“Ranbaxy”), has launched an ...

Amlodipine/atorvastatin (Caduet) is a combination of two drugs, amlodipine (Norvasc) and atorvastatin (Lipitor). Amlodipine is a long-acting dihydropyridine calcium-channel blocker indicated for the ...

Law360, New York (December 20, 2011, 2:35 PM EST) -- A Delaware federal judge on Monday dismissed consolidated patent litigation between Pfizer Inc. and Sandoz Inc. over Pfizer's blood pressure and ...

More co-promotion for Astellas Pharma. The Japanese company inked a deal with Pfizer to promote the latter's combo cardiovascular drug Caduet. Pfizer will make and sell the drug, which puts the ...

Caduet, which combines Pfizer’s top-selling cholesterol-lowering drug atorvastatin with its calcium antagonist amlodipine, was found to reduce the risk of a fatal cardiovascular event, such as a heart ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

Combination products have long been a mainstay of line extension strategies for hypertension products, and the addition of a diuretic has increased sales of many of these products by as much as 20% of ...